Amplicorepharma
1 known investors
Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.
Founders & leadership
TC
Tina ChenDirector of Clinical Affairs
Investors · 1
Frequently asked questions
- What does Amplicorepharma do?
- Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.
- Who are Amplicorepharma's investors?
- Amplicorepharma's investors include Berkeley Catalyst.